The Association Between Adiposity and Survival in Patients with Colorectal Cancer

被引：0

作者：

Durko L. ^{[1
]}

Malecka-Panas E. ^{[1
]}

机构：

[1] Department of Digestive Tract Diseases, Medical University of Lodz, Kopcinskiego 22, Lodz

来源：

Current Nutrition Reports | 2016年 / 5卷 / 1期

关键词：

Adiposity; Body mass index; Colorectal cancer; Survival; Visceral fat;

D O I：

10.1007/s13668-016-0157-7

中图分类号：

学科分类号：

摘要：

Multiple studies confirm the impact of obesity on high incidence of colorectal cancer (CRC). There is a common perception that adiposity and related metabolic dysfunctions result in worse prognosis and decreased survival among patients with a CRC diagnosis. Several epidemiologic studies confirm this observation, however the results are not always consistent, probably due to different techniques used for evaluating the degree of adiposity. Many authors suggest that the most adequate method for assessing this parameter is computer tomography of the abdomen which allows to precisely quantify the amount of adipose tissue. Excess adipose tissue is considered a metabolically active organ releasing numerous adipohormones and cytokines that stimulate chronic inflammation, insulin resistance and contribute to increased cell proliferation. However, adiposity biomarker expression are well-documented risk factors for CRC development, little is known about their prognostic value in this disease. © 2016, Springer Science+Business Media New York.

引用

页码：48 / 53

页数：5

共 47 条

[1]

Ferlay J., Shin H.R., Bray F., Et al., Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008, Int J Cancer, 127, 12, pp. 2893-2917, (2010)

[2]

Ng M., Fleming T., Robinson M., Et al., Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the global burden of disease study 2013, Lancet, 384, 9945, pp. 766-781, (2014)

[3]

Renehan A.G., Tyson M., Egger M., Heller R.F., Zwahlen M., Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies, Lancet, 371, 9612, pp. 569-578, (2008)

[4]

Ning Y., Wang L., Giovannucci E.L., A quantitative analysis of body mass index and colorectal cancer: findings from 56 observational studies, Obes Rev, 11, pp. 19-30, (2010)

[5]

Moghaddam A.A., Woodward M., Huxley R., Obesity and risk of colorectal cancer: a meta-analysis of 31 studies with 70,000 events, Cancer Epidemiol Biomarkers Prev, 16, pp. 2533-2547, (2007)

[6]

Nam S.Y., Kim B.C., Han K.S., Et al., Abdominal visceral adipose tissue predicts risk of colorectal adenoma in both sexes, Clin Gastroenterol Hepatol, 8, pp. 443-450, (2010)

[7]

Lee C.S., Murphy D.J., McMahon C., Et al., Visceral adiposity is a risk factor for poor prognosis in colorectal cancer patients receiving adjuvant chemotherapy, J Gastrointest Cancer, 46, 3, pp. 243-250, (2015)

[8]

Malietzis G., Aziz O., Bagnall N.M., Et al., The role of body composition evaluation by computerized tomography in determining colorectal cancer treatment outcomes: a systematic review, Eur J Surg Oncol, 41, 2, pp. 186-196, (2015)

[9]

Gutierez D.A., Puglisi M.J., Hasty A.H., Impact of increased adipose tissue mass on inflammation, insulin resistance, and dyslipidemia, Curr Diab Rep, 9, 1, pp. 26-32, (2009)

[10]

Calle E.E., Kaaks R., Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms, Nat Rev Cancer, 4, pp. 579-591, (2004)

← 1 2 3 4 5 →